Phase I Study of Direct Administration of a Replication Deficient Adenovirus Vector Containing theE. coliCytosine Deaminase Gene to Metastatic Colon Carcinoma of the Liver in Association with the Oral Administration of the Pro-Drug 5-Fluorocytosine. The New York Hospital-Cornell Medical Center, New York, NY
- 20 May 1997
- journal article
- clinical trial
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 8 (8), 985-1001
- https://doi.org/10.1089/hum.1997.8.8-985
Abstract
No abstract availableThis publication has 43 references indexed in Scilit:
- Gene Therapy for Vascular Smooth Muscle Cell Proliferation After Arterial InjuryScience, 1994
- Treatment of Metastatic Cancer to the LiverSeminars in Liver Disease, 1994
- Adenoviral-mediated gene transfer to renal tubular cells in vivoKidney International, 1994
- Impact of combined modality therapy on the treatment of adenocarcinoma of the colonSeminars in Surgical Oncology, 1993
- Adenovirus–mediated in vivo gene transfer and expression in normal rat liverNature Genetics, 1992
- In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epitheliumCell, 1992
- Colorectal metastases to the liver: Present results and future strategiesJournal of Surgical Oncology, 1991
- Failure Patterns Following Curative Resection of Colonic CarcinomaAnnals of Surgery, 1984
- Natural history of patients with untreated liver metastases from colorectal cancerThe American Journal of Surgery, 1981